Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial

Journal:

The Lancet Oncology

Published:

2025-11-26

DOI:

10.1016/s1470-2045(25)00542-x

Affiliations:

23

Authors:

54

Go to article

Institutions	Authors	Share
Niguarda Hospital, Italy	19.833333 19.833333	0.37
IRCCS European Institute of Oncology (IEO), Italy	11.000000 11.000000	0.20
IRCCS Istituto Oncologico Veneto (IOV), Italy	6.000000	0.11
Azienda Ospedaliera Papa Giovanni XXIII, Italy	5.500000	0.10
IFOM - FIRC Institute of Molecular Oncology, Italy	2.833333	0.05
Candiolo Cancer Institute (FPO-IRCCS), Italy	2.000000	0.04
University of Milan (UNIMI), Italy	1.833333	0.03
University of Padova (UNIPD), Italy	1.500000	0.03
University of Turin (UNITO), Italy	1.500000	0.03
IRCCS Mario Negri Institute, Italy	1.000000	0.02
Sant'Antonio Hospital, Italy	0.500000	0.01
University of Milano-Bicocca (UNIMIB), Italy	0.500000	0.01

Interested in Oncology and Carcinogenesis?